glucokinase activator
Hua Medicine Advances Dorzagliatin Expansion Beyond China with Hong Kong NDA Acceptance
Hua Medicine; dorzagliatin; diabetes drug; China expansion; Hong Kong NDA; Southeast Asia; glucokinase activator
Actionable Insights Powered by AI
Hua Medicine; dorzagliatin; diabetes drug; China expansion; Hong Kong NDA; Southeast Asia; glucokinase activator